The cosmetics supply chain was designed for products that do not degrade. Lipstick, powder, and fragrance have shelf lives measured in years because their active components are chemically stable pigments, waxes, and oils. The same supply chain was inherited by the skincare industry without modification, even though the products it now carries are biologically active formulations that degrade measurably over time.
The warehouse model optimises for scale — large production runs, consolidated distribution, and long shelf lives that allow products to sit on shelves for months or years. This model works when the product is stable. It fails when the product is a complex mixture of peptides, antioxidants, and liposomal delivery systems that begin degrading the moment they are compounded.
The user pays for the warehouse model in two ways: they receive a product that is less effective than the same product used fresh, and the formulation is forced to include higher levels of preservatives, stabilisers, and antioxidants designed to survive the 12-18 month supply chain rather than to perform optimally on skin. The formulation is compromised before the user opens it.
Direct-to-consumer made-to-order manufacturing addresses both problems simultaneously. The product goes from lab to user in days, not months. The formulation can use a lighter preservation system because it does not need to survive a year in a warehouse. The active ingredients are at peak concentration on the day of first use. The only trade-off is operational complexity — which is a business problem, not a biological one.
The assumption that skincare should last two years on a shelf is an artifact of the retail distribution system, not a requirement of the biology. The freshness imperative recognises that biologically active skincare has a limited window of peak efficacy — and that the product should be consumed within that window, not stored through it.